Flatiron Taps Vasoncelles of Unum Therapeutics for Chief Medical Officer

Michael Vasoncelles has joined Flatiron Health as chief medical officer, the same position he held at Unum Therapeutics. Vasoncelles’ experience also includes posts at Takeda Pharmaceutical (NYSE: [[ticker:TAK]]), Genzyme, and Sanofi (NYSE: [[ticker:SNY]]). At New York-based Flatiron, Vasoncelles will succeed Amy Abernethy, who left earlier this year to join the FDA as principal deputy commissioner. Flatiron, which has developed software that analyzes electronic health record data for cancer research, was acquired by Roche last year for $1.9 billion.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan